HLA antigens in the Guillain-Barré syndrome.
HLA typing for class I and II antigens was performed on 89 caucasoid patients with Guillain-Barré syndrome and compared with controls. No significant association, between HLA type and susceptibility to disease, prognosis at 12 months or antecedent event was discovered. HLA antigen DR2 was more frequent among patients with the most profound muscle weakness.
Winer
J B
JB
Department of Neurology United Medical School Guy's Hospital, London, U.K.
Briggs
D
D
Welsh
K
K
Hughes
R A
RA
D002169:Campylobacter Infections / Q000150:complications; D003586:Cytomegalovirus Infections / Q000150:complications; D004198:Disease Susceptibility; D006680:HLA Antigens / Q000032:analysis*; D006684:HLA-DR Antigens / Q000032:analysis; D015802:HLA-DR2 Antigen; D006801:Humans; D011129:Polyradiculoneuropathy / Q000209:etiology / Q000276:immunology* / Q000473:pathology; D011379:Prognosis
D006680:HLA Antigens; D006684:HLA-DR Antigens; D015802:HLA-DR2 Antigen